Cadila Pharmaceuticals launched Mycidac-C, a lung cancer drug

Mycidac-C, a new lung cancer drug was launched by Cadila Pharmaceuticals. The 10 course injection of the drug is priced 40000 rupees.

Created On: Nov 22, 2013 11:11 ISTModified On: Dec 20, 2013 12:36 IST

Cadila Pharmaceuticals on 21 November 2013 launched a new lung cancer drug, Mycidac-C, which is priced 40000 rupees for 10 course injection. The drug is much cheaper than the drugs manufactured by the multinational companies.

Cadila developed the drug after 15 years research and it will be available in Indian market from December 2013. Mycidac-C has been licensed and approved by the Drug Controller General of India (DCGI). The drug, Mycidac-C is meant for the patients, who suffer from non-small cell lung cancer (NSCLC).

If you have any Question/Point on the above information, please ask/discuss it in the Current Affairs Group

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप


Related Stories

Comment (0)

Post Comment

4 + 5 =
Disclaimer: Comments will be moderated by Jagranjosh editorial team. Comments that are abusive, personal, incendiary or irrelevant will not be published. Please use a genuine email ID and provide your name, to avoid rejection.

    Monthly Current Affairs PDF

    • Current Affairs PDF November 2021
    • Current Affairs PDF October 2021
    • Current Affairs PDF September 2021
    • Current Affairs PDF August 2021
    • Current Affairs PDF July 2021
    • Current Affairs PDF June 2021
    View all

    Monthly Current Affairs Quiz PDF

    • Current Affairs Quiz PDF November 2021
    • Current Affairs Quiz PDF October 2021
    • Current Affairs Quiz PDF September 2021
    • Current Affairs Quiz PDF August 2021
    • Current Affairs Quiz PDF July 2021
    • Current Affairs Quiz PDF June 2021
    View all